换一批
换一批Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy.
作者：
主题词
成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 移行细胞(Carcinoma, Transitional Cell);顺铂(Cisplatin);脱氧胞苷(Deoxycytidine);多柔比星(Doxorubicin);用药计划表(Drug Administration Schedule);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);人类(Humans);输注, 静脉内(Infusions, Intravenous);男(雄)性(Male);甲氨蝶呤(Methotrexate);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);紫杉酚(Paclitaxel);存活率分析(Survival Analysis);治疗结果(Treatment Outcome);膀胱肿瘤(Urinary Bladder Neoplasms);长春碱(Vinblastine)
DOI
10.1002/1097-0142(20011215)92:12<2993::aid-cncr10108>3.0.co;2-2
PMID
11753976
发布时间
2022-12-07
- 浏览6
Cancer
2993-8页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
